Our February issue is live!

Welcome to this week's edition of Dermatology Times' LinkedIn newsletter!

We're excited to share that our February issue is now live on our website. We invite you to visit our website to download and explore the issue, which features insights into emerging therapies for pigmentary disorders, a reflection on the history and use of botulinum toxins, and clinician insights into patient journeys with chronic spontaneous urticaria.

If you haven't yet subscribed to receive physical copies of our publication, we invite you to do so here.

If you have questions, suggestions, or would like to contribute to a future edition, please contact us via LinkedIn or via email at [email protected].

?? February Issue Spotlight

Our cover story highlights pigmentary disorders. While not life-threatening, they significantly impact patients' quality of life and present therapeutic challenges. Rebecca Urbonas; Sumrah Jilani; and Bernard A. Cohen, MD, highlight recent advancements in vitiligo treatment, melasma management, and postinflammatory hyperpigmentation solutions. Despite progress, personalized approaches and long-term maintenance strategies are essential for improved outcomes.

Mona Gohara, M.D. , highlights how Allergan Aesthetics, an AbbVie Company science-driven approach, commitment to patient safety, and focus on empowering women continue to shape dermatology through Botox Cosmetic. Originally discovered by Jean and Alastair Carruthers in the 1980s, Botox has evolved into the leading neurotoxin for both aesthetic and therapeutic applications, including hyperhidrosis and temporomandibular disorders.

Jason Hawkes, MD, shares his personal experience with chronic cold urticaria and discussed advancements in treatment, including the use of antihistamines, omalizumab, and emerging therapies like dupilumab and remibrutinib. Despite these advances, unmet needs remain, particularly in predicting treatment responses through biomarkers. Hawkes emphasized the importance of personalized treatment approaches and the evolving therapeutic landscape for urticaria patients.

?? Research Roundup

Merz Aesthetics ’ Pillars of Confidence study, conducted with 益普索 , surveyed 15,000 adults across 15 countries to explore the relationship between self-confidence, aesthetic treatments, and well-being. The results showed that 73% of participants felt empowered after a procedure, with many seeking treatments to align their appearance with their self-perception. The study also highlighted the growing normalization of aesthetic treatments as part of self-care, with 66% using them to manage aging and 59% considering them part of their beauty routine, reinforcing their role in confidence-building and personal empowerment.

Gerry Muhle and Michael Somenek , MD, discussed findings from Galderma 's phase 4 study on combining Sculptra with Restylane Lyft or Contour for facial volume restoration following medication-induced weight loss. Muhle highlighted the increasing demand for treatments addressing facial fat loss, collagen depletion, and skin laxity, emphasizing a holistic, individualized approach to aesthetic care. Somenek, a study investigator, noted that the combination treatment improved volume, skin hydration, and confidence, with nearly 90% of participants reporting satisfaction, marking a significant step toward regenerative aesthetics and future innovations in facial rejuvenation.

A recent study highlights disparities in burn care outcomes among racial and ethnic minorities, particularly Black and Hispanic patients, who experience delayed treatment, lower survival rates, and increased post-burn complications like hypertrophic scarring and hypopigmentation. The research underscores challenges in burn assessment for darker skin tones, where erythema presents differently, leading to potential misdiagnosis. Experts stress the need for inclusive assessment tools, tailored treatment protocols, and increased representation in clinical research to ensure equitable burn care and improved outcomes for all patients.

?? Continuing Education Opportunities

Dermatology Times editors will be onsite at South Beach Symposium 2025, and we’d love for you to join us! Clinicians can use the code provided for 50% off registration. Don’t miss this opportunity to connect, learn, and engage with top experts in the field. See you in South Beach!

Discover ways to further your education and knowledge of specific disease states by exploring CME opportunities from Physicians' Education Resource?, LLC (PER?) below.

For more information, visit PER's website or click on the graphic below.

Thank you for reading!